Related Experiment Video
Updated: Jun 23, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Expression, regulation and function of the ISGylation system in prostate cancer
A Kiessling1, C Hogrefe, S Erb
1Medical Faculty, Institute for Medical Immunology, Martin-Luther-University Halle-Wittenberg, Halle, Germany. Andrea.Kiessling@novartis.com
Abstract:
The androgen receptor (AR) plays a crucial role in the modulation of prostate cell proliferation and is involved in the development and progression of prostate cancer (PCa). An understanding of the complex regulation of AR provides novel treatment options for PCa. Here, we show (i) that the ubiquitin-like modifier, interferon-stimulated gene 15 (ISG15), and most enzymes involved in ISG15 conjugation were upregulated in tumor samples versus in non-malignant tissues of PCa patients and (ii) that the expression of these components significantly differed between tumors in patients treated with and without androgen ablation. Using PCa cell lines as in vitro models, the specific androgen-mediated, AR-dependent regulation of the ISGylation components was confirmed. In addition, the ISGylation system controls AR mRNA and protein expressions, as overexpression of Ube1L as a limiting ISGylation factor in the AR(+) androgen-sensitive PCa cell line, LNCaP, results in significant AR upregulation, accompanied by an increased proliferation even under androgen deprivation. Accordingly, Ube1L knockdown decreased the AR expression. Thus, this study describes for the first time the modulation of AR expression by ISGylation components, which affects the proliferation of PCa cells, thereby providing evidence for a novel function of the ISGylation system in malignant transformation.
Insights
Interferon-stimulated gene 15 (ISG15) and its conjugation enzymes are upregulated in prostate cancer (PCa) tumors. This ISGylation system modulates androgen receptor (AR) expression and PCa cell proliferation, offering new therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The androgen receptor (AR) is critical for prostate cell proliferation and prostate cancer (PCa) progression.
- Understanding AR regulation offers potential new PCa treatment strategies.
Purpose of the Study:
- To investigate the role of interferon-stimulated gene 15 (ISG15) conjugation in AR regulation and PCa cell proliferation.
- To determine if ISGylation components are differentially expressed in PCa tissues and correlate with treatment status.
Main Methods:
- Analysis of ISG15 and conjugation enzyme expression in PCa tumor samples versus non-malignant tissues.
- In vitro studies using PCa cell lines to assess androgen-mediated regulation of ISGylation components.
- Investigating the effect of Ube1L (a key ISGylation factor) overexpression and knockdown on AR expression and cell proliferation.
Main Results:
- ISG15 and its conjugation enzymes were upregulated in PCa tumors compared to normal tissues.
- Expression levels differed significantly between patients treated with and without androgen ablation.
- ISGylation system components were confirmed to be androgen-mediated and AR-dependent.
- Overexpression of Ube1L increased AR mRNA and protein levels, enhancing proliferation even without androgens.
- Ube1L knockdown led to decreased AR expression.
Conclusions:
- The ISGylation system modulates AR expression and influences PCa cell proliferation.
- This study reveals a novel function of the ISGylation system in prostate cancer development and progression.
- Targeting the ISGylation pathway presents a potential new therapeutic approach for PCa.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Regulation of Expression at Multiple Steps
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
GTPases and their Regulation
Large G-proteins, also known...
GPCRs Regulate Adenylyl Cylase Activity
Two...